Cyclohexylamine

Cyclohexylamine

SCHEMBL3142573

C1CCC(NC2CCCCC2)CC1.NC1CCCCC1

nearest known ligand 0.71

Full drug profile on Sugi Atlas →

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 3/20 0.71
HSD17B10 Q99714 1/20 0.71
ADH1B P00325 2/20 0.42
ADH1C P00326 2/20 0.42
ADH1A P07327 2/20 0.42
ADH4 P08319 1/20 0.42
CA1 P00915 2/20 0.39
CA2 P00918 1/20 0.39
ADH7 P40394 1/20 0.38
EPHX1 P07099 5/20 0.36
CYP3A4 P08684 2/20 0.36
NPC1 O15118 2/20 0.36
RAB9A P51151 2/20 0.36
SMN1; SMN2 Q16637 2/20 0.36
CA12 O43570 1/20 0.36
CA7 P43166 1/20 0.36
CA14 Q9ULX7 1/20 0.36
TP53 P04637 1/20 0.36
MAPT P10636 1/20 0.36
KDM4E B2RXH2 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Cyclohexylamine SCHEMBL8025766 1.00 ALDH1A1 (0.71) ALDH1A1HSD17B10ADH1BADH1CADH1A
SCHEMBL14459899 1.00 ALDH1A1 (0.71) ALDH1A1HSD17B10ADH1BADH1CADH1A
SCHEMBL16121130 0.97 ALDH1A1 (0.67) ALDH1A1HSD17B10ADH1BADH1CADH1A
SCHEMBL2606443 0.92 ALDH1A1 (0.67) ALDH1A1HSD17B10ADH1BADH1CADH1A
SCHEMBL21799565 0.85 ALDH1A1 (0.57) ALDH1A1HSD17B10ADH1BADH1CADH1A
SCHEMBL18899183 0.85 ALDH1A1 (0.57) ALDH1A1HSD17B10ADH1BADH1CADH1A
SCHEMBL24771540 0.84 ALDH1A1 (1.00) ALDH1A1HSD17B10ADH1BADH1CADH1A
SCHEMBL24771539 0.84 ALDH1A1 (1.00) ALDH1A1HSD17B10ADH1BADH1CADH1A
SCHEMBL21375316 0.84 ALDH1A1 (1.00) ALDH1A1HSD17B10ADH1BADH1CADH1A
SCHEMBL24839013 0.84 ALDH1A1 (1.00) ALDH1A1HSD17B10ADH1BADH1CADH1A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 12 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2010026603-A2 NOVEL AMINE SALTS OF TENOFOVIR, PROCESS FOR PRODUCING THE SAME AND USE THEREOF IN PRODUCTION OF TENOFOVIR DIOPROXIL MATRIX LABORATORIES LIMITED (IN) 2010-03-11 WO claimed
US-12496285-B2 Compositions and methods using at least one glycine or derivative thereof, at least one N-acetylcysteine or derivative thereof, and at least one nicotinamide riboside or NAD+ precursor SOCIETE DES PRODUITS NESTLE S.A. (CH) 2025-12-16 US disclosed
US-20240091186-A1 COMPOSITIONS AND METHODS USING AT LEAST ONE GLYCINE OR DERIVATIVE THEREOF, AT LEAST ONE N-ACETYLCYSTEINE OR DERIVATIVE THEREOF, AND AT LEAST ONE NICOTINAMIDE RIBOSIDE OR NAD+ PRECURSOR SOCIETE DES PRODUITS NESTLE S.A. (CH) 2024-03-21 US disclosed
CN-117510343-A Treatment method of aniline tar 中国石油化工股份有限公司 2024-02-06 CN disclosed
EP-3075757-B1 POLYAMIDE RESIN AND POLYAMIDE MOLDED BODY USING SAME LOTTE ADVANCED MAT CO LTD (KR) 2020-04-01 EP disclosed
US-9796814-B2 Polyamide resin and polyamide molded body using same LOTTE ADVANCED MATERIALS CO., LTD. (KR) 2017-10-24 US disclosed
EP-3075757-A1 POLYAMIDE RESIN AND POLYAMIDE MOLDED BODY USING SAME Samsung SDI Co., Ltd. (KR) 2016-10-05 EP disclosed
US-20160280855-A1 Polyamide Resin and Polyamide Molded Body Using Same LOTTE ADVANCED MATERIALS CO., LTD. (KR) 2016-09-29 US disclosed
WO-2010026603-A2 NOVEL AMINE SALTS OF TENOFOVIR, PROCESS FOR PRODUCING THE SAME AND USE THEREOF IN PRODUCTION OF TENOFOVIR DIOPROXIL MATRIX LABORATORIES LIMITED (IN) 2010-03-11 WO disclosed
US-6806289-B1 SUCH AS AMMINE (2-AMINO-3-PICOLINE) DICHLOROPLATINUM(II); EFFICIENCY AND SELECTIVITY FOR DESTROYING TRANSFORMED CELLS NATIONAL INSTITUTES OF HEALTH (NIH), U.S. DEPT. OF HEALTH AND HUMAN SERVICES (DHHS), U.S. GOVERNMENT 2004-10-19 US disclosed
WO-2003027132-A2 METHOD OF PREPARING 17β-(N-TERT-BUTYLCARBAMOYL)-3-ONE STEROID DERIVATIVES HANMI PHARM. CO., LTD. (KR) 2003-04-03 WO disclosed
US-4902661-A CATALYTIC DEHYDROGENATION OF DICYCLOHEXYLAMINE BAYER AKTIENGESELLSCHAFT (DE) 1990-02-20 US disclosed